儿童MODY12型临床特征与预后分析
该回顾性病例研究分析北京儿童医院2016年1月至2023年12月收治的5例ABCC8基因变异所致MODY12型患儿,发现起病年龄从婴儿期至青春期,临床异质性强,可表现为轻度高血糖至酮症酸中毒,肥胖发生率高,个体化治疗后血糖控制较好。
要点
- MODY12型起病年龄范围广,临床异质性强,可轻可重。
- ABCC8基因变异以错义变异为主,均为母源杂合遗传。
- 根据血糖情况个体化治疗,随访血糖控制较好。
核心结论
- MODY12型患儿起病年龄从婴儿期至青春期,临床异质性强,从轻度血糖升高到酮症酸中毒起病,肥胖发生率高,以ABCC8基因错义变异为主,个体化治疗血糖控制较好。
研究设计与样本
- 回顾性病例研究,收集2016年1月至2023年12月于北京儿童医院住院及门诊就诊的5例ABCC8基因变异所致MODY12型患儿病例资料,分析临床特点、治疗随访和遗传学特点。
主要发现
- 5例中男4例、女1例,年龄13.4(5.5,14.6)岁;出生时巨大儿4例,小于胎龄儿1例;2例合并超重或肥胖。
- 3例有典型糖尿病症状,2例无意中发现血糖高;1例以糖尿病酮症酸中毒起病,该患儿新生儿期诊断先天性高胰岛素血症,二氮嗪治疗有效,伴智力发育落后。
- 5例患儿家族中均有连续三代常染色体显性遗传的糖尿病史。
- 起病时空腹血糖7.5(6.5,10.0)mmol/L,HbA1c为11.8%(7.5%,13.5%),空腹C肽1.2(1.1,2.2)μg/L;随访时间15(9,32)个月。
- 随访时空腹血糖6.1(5.1,7.0)mmol/L,HbA1c为5.9%(5.7%,7.1%),空腹C肽1.7(0.9,2.9)μg/L;1例并发糖尿病视网膜病变。
关键数值与推荐
- 5例患儿共发现4个ABCC8基因杂合错义变异和1个整码缺失,均来源于母亲。
- 治疗方式:1例生活方式干预,2例口服二甲双胍,1例胰岛素加磺脲类药物治疗,1例胰岛素治疗。
临床怎么用
- 对疑似MODY12型患儿应进行ABCC8基因检测以明确诊断。
- 根据血糖水平个体化制定治疗方案,可选择生活方式干预、二甲双胍、胰岛素或胰岛素联合磺脲类药物。
- 随访中需监测血糖、HbA1c、C肽及糖尿病并发症。
局限性
- 样本量小(5例),为单中心回顾性研究,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the genetic and clinical characteristics, treatment and prognosis of patients diagnosed with maturity onset of diabetes of the young (MODY) 12 subtype. Methods: This retrospective study collected and analyzed data from 5 children with MODY12 subtype caused by ABCC8 gene variants who underwent inpatient and outpatient genetic testing at Beijing Children's Hospital from January 2016 to December 2023. Their clinical and genetic features, treatment, and follow-up results were analyzed. Results: Among the 5 patients with MODY12 subtype, 4 were male and 1 was female, with an age of 13.4 (5.5, 14.6) years. Four of the patients were born large for gestational age, while one was born small for gestational age. Two patients were overweight or obese. Three patients exhibited typical symptoms of diabetes, while 2 were incidentally found to have elevated blood glucose level. One patient was found to have diabetic ketoacidosis at onset, who was diagnosed with congenital hyperinsulinism during the neonatal period and received diazoxide treatment, and experienced intellectual developmental delay. All 5 patients had autosomal dominant inherited diabetes within 3 generations. The fasting blood glucose at onset was 7.5 (6.5, 10.0) mmol/L, the haemoglobin A1c (HbA1c) was 11.8% (7.5%, 13.5%), and the fasting C-peptide was 1.2 (1.1, 2.2) μg/L. The duration of follow-up was 15 (9, 32) months. One patient underwent lifestyle intervention, 2 received metformin orally, 1 received insulin therapy, and the other received subcutaneous injection of insulin combined with sulfonylurea orally. At the last follow-up, the median fasting blood glucose was 6.1 (5.1, 7.0) mmol/L, the HbA1c was 5.9% (5.7%, 7.1%), and the fasting C-peptide was 1.7 (0.9, 2.9) μg/L. One patient developed diabetic retinopathy. There were 4 missense variations in ABCC8 gene and one in-frame deletion, all of which were maternally inherited heterozygotes. Conclusions: MODY12 subtype is a heterogeneous disorder with the age of onset from infancy to adolescence. It can present as mild hyperglycemia or diabetic ketoacidosis, and has a high incidence of obesity. Definitive diagnosis can be achieved through genetic test, and individualized treatment is recommended based on glucose levels. 目的: 了解青少年起病的成人型糖尿病(MODY)12型的临床特点、基因变异及治疗随访结局。 方法: 回顾性病例研究。收集2016年1月至2023年12月于北京儿童医院住院及门诊就诊5例MODY12型患儿病例资料,基因检测结果均提示ABCC8基因变异,分析其临床特点,治疗随访情况和遗传学特点。 结果: 5例MODY12型中男4例、女1例,年龄为13.4(5.5,14.6)岁。出生时巨大儿4例,小于胎龄儿1例。2例合并超重或者肥胖,3例有典型糖尿病症状,2例无意中发现血糖高。1例以糖尿病酮症酸中毒起病患儿新生儿期诊断先天性高胰岛素血症,二氮嗪治疗有效,伴智力发育落后。5例患儿家族中均有连续三代常染色体显性遗传的糖尿病史。起病时的空腹血糖7.5(6.5,10.0)mmol/L,糖化血红蛋白(HbA1c)为11.8%(7.5%,13.5%),空腹C肽1.2(1.1,2.2)μg/L,随访时间15(9,32)个月,1例生活方式干预,2例口服二甲双胍,1例胰岛素加磺脲类药物治疗,1例胰岛素治疗。随访时的空腹血糖6.1(5.1,7.0)mmol/L,HbA1c为5.9%(5.7%,7.1%),空腹C肽1.7(0.9,2.9)μg/L。1例并发糖尿病视网膜病变。5例患儿共发现4个ABCC8基因杂合错义变异,1个整码缺失,均来源于母亲。 结论: MODY12型患儿起病年龄从婴儿期至青春期,临床异质性强,从轻度血糖升高到酮症酸中毒起病,肥胖发生率高,以ABCC8基因错义变异为主。个体化地根据血糖情况制定治疗方案,血糖控制较好。.
引用
- Cao BY, Miao M, Wang DM, et al. [Clinical characteristics and prognosis of 5 children with maturity onset of diabetes of the young 12 subtype]. Zhonghua Er Ke Za Zhi. 2024. PMID: 38763874. doi:10.3760/cma.j.cn112140-20231127-00391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。